Firstly, we analyzed the clinical significance of S100A7 and cPLA2 (PLA2G4A) in invasive breast cancer using publically available breast cancer datasets and human breast cancer tissue microarray (TMAs) by immunohistochemistry analysis. This evidence concerns the gene S100A7 and invasive breast carcinoma.